Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 292Lymphoma 45Recurrence 31Neoplasms, Plasma Cell 28Hematologic Neoplasms 25Smoldering Multiple Myeloma 20Lymphoma, Non-Hodgkin 20Neoplasms 13Leukemia, Lymphocytic, Chronic, B-Cell 11Myelodysplastic Syndromes 10Leukemia 10Immunoglobulin Light-chain Amyloidosis 10Leukemia, Myeloid, Acute 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myeloproliferative Disorders 8Hodgkin Disease 8Waldenstrom Macroglobulinemia 7Lymphoma, Mantle-Cell 6Prostatic Neoplasms 5Paraproteinemias 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Breast Neoplasms 5Lymphoproliferative Disorders 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hematologic Diseases 4Colorectal Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Patient Participation × Plasma cell × Clear all
NCT05673083 2025-09-04

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

All4Cure

Active not recruiting
200 enrolled
Plasma cell

Multiple Myeloma, Patient Participation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡